ESPE Abstracts (2023) 97 T6

ESPE2023 Top 20 Posters Section (20 abstracts)

Granulosa cell tumors in girls: Preliminary results of a meta-analysis of new and published cases

Eszter Kiss 1 , Sandra Wessmann 2,3 , Joseph W Carlson 2,4 , Elena Lundberg 5 , Margaretha Stenmarker 6,7,8 , Johan Bobeck 9 & Maria Lodefalk 1,10


1Department of Pediatrics, Örebro University Hospital, Örebro, Sweden. 2Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. 3Department of Pathology and Cancer diagnostics, Karolinska University Hospital, Stockholm, Sweden. 4Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA. 5Institute of Clinical Science/Pediatrics, Umeå University, Umeå, Sweden. 6Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. 7Futurum/Department of Paediatrics, Region Jönköping County, Jönköping, Sweden. 8Department of Paediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 9Departement of Pediatrics, Region Kalmar, Kalmar, Sweden. 10University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden


Background: Granulosa cell tumors (GCT) originate from sex cord/stromal tissue in the gonad. They are typically located in an ovary, but extra-gonadal localisation exists. These tumors are extremely rare in children and no systematic review has been published. The objective of this systematic review is to examine the following questions: What is the clinical picture of girls with a GCT? How are these patients treated and what is their prognosis?

Methods: To be included in the review, the article had to present a new case with GCT fulfilling the following criteria: female human fetus or a girl aged < 19 years with clinical information included a tumor containing granulosa cells. The databases MEDLINE, Embase, Web of Science, and CINAHL were searched in November 2021. To find new cases, we asked pediatric endocrinologists in Sweden to report patients after informed consent had been secured. We also collected data from a Swedish paediatric reference pathology laboratory.

Results: The search identified 1,894 published references of which 35 were duplicates. We have screened 1,859 abstracts. We are in the process of reading 824 selected articles in full text to check for eligibility. Individual participant data has been extracted from 20 of the published reports for preliminary results. Nineteen new Swedish cases with a GCT were identified. The preliminary analysis of 39 patients´ data shows an average age of 7.3 years at the time of diagnosis (range: antenatal diagnosis up to 18 years of age). Symptoms at presentation were: prepubertal breast enlargement, vaginal discharge/bleeding, abdominal distension or pain, pubic hair growth, fever, constipation, swelling of vulva or cliteromegaly, hyperpigmentation of the skin, primary/secondary amenorrhea, headache, hirsutism and advanced linear growth. The histopathological diagnosis was juvenile GCT in 76.9%, adult GCT in 12.8%, a mixed type of juvenile and adult GCT in 7.7% and another type of tumor containing granulosa cell component in 2.6% of the cases. All patients received surgical treatment except one with a post-mortem GCT diagnoses. Adjuvant chemotherapy was administered in two cases. Three patients (7.7%) died, two of them due to late discovery of the primary tumor and one secondary to local recurrence of the tumor with metastases 4 years after the primary diagnosis.

Conclusion: GCT can present in all pediatric ages and often, but far from always, with endocrine symptoms such as peripheral precautious puberty. Data from this systematic review will hopefully promote early recognition of this malignant disease.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.